drugset / Trial / NCT07542483
A Study of Lebrikizumab in Adults With Nummular Eczema
RandomizedParallel-groupDouble-blindTreatment
Summary
The main aim of the study is to evaluate the efficacy, safety, and tolerability of lebrikizumab treatment in adult participants with Nummular Eczema (NE) who are not adequately controlled with Topical corticosteroids (TCS) or when this treatment is not medically advisable.
Timeline
- Start
- 2026-04
- Primary completion
- 2028-08
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lebrikizumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.